title: Response to letter regarding article, "lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER trial (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin)".
authors.affiliation: Center for Cardiovascular Disease Prevention, Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
authors.forename: Amit V
authors.initials: AV
authors.lastname: Khera
authors.affiliation: Center for Cardiovascular Disease Prevention, Division of Preventive Medicine and Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
authors.forename: Brendan M
authors.initials: BM
authors.lastname: Everett
authors.affiliation: Quest Diagnostics Nichols Institute, San Juan Capistrano, CA.
authors.forename: Michael P
authors.initials: MP
authors.lastname: Caulfield
authors.affiliation: Quest Diagnostics Nichols Institute, San Juan Capistrano, CA.
authors.forename: Feras M
authors.initials: FM
authors.lastname: Hantash
authors.affiliation: Quest Diagnostics Nichols Institute, San Juan Capistrano, CA.
authors.forename: Jay
authors.initials: J
authors.lastname: Wohlgemuth
authors.affiliation: Center for Cardiovascular Disease Prevention, Division of Preventive Medicine and Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
authors.forename: Paul M
authors.initials: PM
authors.lastname: Ridker
authors.affiliation: Center for Cardiovascular Disease Prevention, Division of Preventive Medicine and Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
authors.forename: Samia
authors.initials: S
authors.lastname: Mora
mesh_terms: D002318:Cardiovascular Diseases; D005260:Female; D005464:Fluorobenzenes / Q000008:administration & dosage*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D017270:Lipoprotein(a) / Q000097:blood*; D008297:Male; D011743:Pyrimidines / Q000008:administration & dosage*; D013449:Sulfonamides / Q000008:administration & dosage*
chemical_list: D005464:Fluorobenzenes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D017270:Lipoprotein(a); D011743:Pyrimidines; D013449:Sulfonamides